Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Dupuytren Contracture × Adalimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 9 Psoriasis 3 Spondylitis, Ankylosing 2 Crohn Disease 2 Uveal Melanoma 1 Thyroid Carcinoma, Anaplastic 1 Spondylarthritis 1 Sarcoidosis 1 Plaque Psoriasis 1 Osteoarthritis 1 Nephrotic Syndrome 1 Nephrosis, Lipoid 1 Mucopolysaccharidosis VI 1 Mucopolysaccharidosis II 1 Mucopolysaccharidosis I 1 Mucopolysaccharidoses 1 Melanoma 1 Macular dystrophy, corneal type 1 1 Kidney Diseases 1 Joint Diseases 1 Inflammation 1 Healthy Adult Male 1 Healthy 1 Glomerulosclerosis, Focal Segmental 1 Dupuytren Contracture 1 Colitis, Ulcerative 1 Autoimmune Diseases 1 Arthritis 1

Interventions

Microbial Collagenase 12 xiapex 8 Surgical Procedures, Operative 2 Collagenases 2 Triamcinolone Acetonide 1 Transplantation 1 Tranexamic Acid 1 Therapeutics 1 Surveys and Questionnaires 1 Sodium Chloride 1 Restraint, Physical 1 Radiotherapy 1 Oxycodone 1 Ibuprofen 1 Extracorporeal Shockwave Therapy 1 Dexamethasone 1 Adalimumab 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03180957 2024-06-28

RIDD

University of Oxford

Phase 2 Completed

140 enrolled 29 charts

Dupuytren Contracture

Data powered by HemOnc (CC BY 4.0) Colophon ⚡